Clinical Tuberculosis
Editat de Lloyd N. Friedman, Martin Dedicoat, Peter D. O. Daviesen Limba Engleză Hardback – 27 aug 2020
Key Features
- Completely updated and reorganized
- Includes brand new chapters on radiology and an overview of the latest WHO, ATS/CDC/IDSA, ERS, NICE, CTS and IUATLD guidelines
- Clinically focused to provide up-to-date guidance on diagnosis, treatment and control
- Edited by three renowned experts in the field of tuberculosis
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 642.04 lei 6-8 săpt. | +303.27 lei 10-14 zile |
| CRC Press – 29 apr 2022 | 642.04 lei 6-8 săpt. | +303.27 lei 10-14 zile |
| Hardback (1) | 964.05 lei 6-8 săpt. | |
| CRC Press – 27 aug 2020 | 964.05 lei 6-8 săpt. |
Preț: 964.05 lei
Preț vechi: 1299.48 lei
-26% Nou
Puncte Express: 1446
Preț estimativ în valută:
184.56€ • 200.41$ • 155.21£
184.56€ • 200.41$ • 155.21£
Carte tipărită la comandă
Livrare economică 14-28 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780815370239
ISBN-10: 0815370237
Pagini: 467
Ilustrații: 1 Tables, color; 47 Tables, black and white; 33 Illustrations, color; 117 Illustrations, black and white
Dimensiuni: 210 x 280 x 28 mm
Greutate: 1.24 kg
Ediția:6 New edition
Editura: CRC Press
Colecția CRC Press
ISBN-10: 0815370237
Pagini: 467
Ilustrații: 1 Tables, color; 47 Tables, black and white; 33 Illustrations, color; 117 Illustrations, black and white
Dimensiuni: 210 x 280 x 28 mm
Greutate: 1.24 kg
Ediția:6 New edition
Editura: CRC Press
Colecția CRC Press
Public țintă
Professional ReferenceCuprins
Foreword. Preface. Editors. Contributors. I. BACKGROUND. The History of Tuberculosis from Earliest Times to the Development of Drugs. Epidemiology. II. PATHOLOGY AND IMMUNOLOGY. Mycobacterium tuberculosis: The Genetic Organism. Pathogenesis of Tuberculosis. III. TRANSMISSION. Using Genotyping and Molecular Surveillance to Investigate Tuberculosis Transmission. Tuberculosis Transmission Control. IV. DIAGNOSIS OF ACTIVE DISEASE AND LATENTINFECTION. Diagnosis of Active Pulmonary Tuberculosis. Radiology of Mycobacterial Disease. Diagnosis of Latent TB Infection. V. DRUGS AND VACCINES FORTUBERCULOSIS. Clinical Pharmacology of the Anti-Tuberculosis Drugs. New Developments in Drug Treatment. BCG and Other Vaccines. VI. CLINICAL ASPECTS AND TREATMENT. Pulmonary Tuberculosis. Extrapulmonary Tuberculosis. Tuberculosis and Human Immunodeficiency Virus Coinfection. Drug-Resistant Tuberculosis. The Surgical Management of Tuberculosis and Its Complications. Tuberculosis in Childhood and Pregnancy. Treatment of Latent Tuberculosis Infection Including Risk Factors for the Development of Tuberculosis. VII. OFFICIAL STATEMENTS: COMPARISON OF NATIONAL AND INTERNATIONAL RECOMMENDATIONS. Treatment Guidelines for Active Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis, and Latent Tuberculosis Infection. VIII. CONTROL. Tuberculosis Epidemic Control: A Comprehensive Strategy to Drive Down Tuberculosis. IX. RELATED ASPECTS. Animal Tuberculosis. Index.
Notă biografică
Lloyd N. Friedman, M.D., is a Clinical Professor of Pulmonary, Critical Care and Sleep Medicine at the Yale School of Medicine, New Haven, CT. He is Director of Inpatient Quality and Safety for the Department of Internal Medicine. He is a member of the American Thoracic Society, a member of the Society of Critical Care Medicine, a fellow of the American College of Chest Physicians and a member of the International Union Against Tuberculosis and Lung Disease. He is Chairman of the Connecticut Tuberculosis Elimination Advisory Committee.
Martin Dedicoat PhD, FRCP, BSc, DTM&H is a Consultant physician in infectious diseases at the University Hospitals Birmingham. He is currently clinical lead for tuberculosis for Birmingham and Solihull, UK. His main research interests center around tuberculosis transmission in urban settings. Dr Dedicoat is a member of the British Thoracic Society drug resistant tuberculosis management group advising on management of complex tuberculosis patients across the UK. He also sits on the National Tuberculosis board for England.
Dr. Peter D. O. Davies graduated in 1966 from Marlborough College, Wilts, UK and obtained his BM, BCh and MA from University College, Oxford, UK in 1971 and St. Thomas’s Hospital in London in 1973. He gained a DM from oxford in 1984. He was a Consultant General and Respiratory Physician at Aintree University Hospital from 1988 to 2011 and at Liverpool Heart Chest Hospital from 1988 to 2015. He is or has been a member of the British Medical Association, the British Thoracic Society, the European Respiratory Society, the Royal College of Physicians of London (Fellow), the Royal Society of Medicine, the American Thoracic Society, the North Western Society of Respiratory Physicians where he served as President in 2007, the International Union Against Tuberculosis and Lung Disease where he was Chair of the Tuberculosis Section, President of the European section, and Editor in Chief of the International Journal of Tuberculosis and Lung Disease, and a member of NICE where he was chair of the Tuberculosis Section. He co-founded the UK Based TB charity in 1998. Dr. Davies is an expert in tuberculosis and edited the inaugural edition of the textbook, Clinical Tuberculosis in 1994 and has continued as editor for the subsequent 5 editions.
Martin Dedicoat PhD, FRCP, BSc, DTM&H is a Consultant physician in infectious diseases at the University Hospitals Birmingham. He is currently clinical lead for tuberculosis for Birmingham and Solihull, UK. His main research interests center around tuberculosis transmission in urban settings. Dr Dedicoat is a member of the British Thoracic Society drug resistant tuberculosis management group advising on management of complex tuberculosis patients across the UK. He also sits on the National Tuberculosis board for England.
Dr. Peter D. O. Davies graduated in 1966 from Marlborough College, Wilts, UK and obtained his BM, BCh and MA from University College, Oxford, UK in 1971 and St. Thomas’s Hospital in London in 1973. He gained a DM from oxford in 1984. He was a Consultant General and Respiratory Physician at Aintree University Hospital from 1988 to 2011 and at Liverpool Heart Chest Hospital from 1988 to 2015. He is or has been a member of the British Medical Association, the British Thoracic Society, the European Respiratory Society, the Royal College of Physicians of London (Fellow), the Royal Society of Medicine, the American Thoracic Society, the North Western Society of Respiratory Physicians where he served as President in 2007, the International Union Against Tuberculosis and Lung Disease where he was Chair of the Tuberculosis Section, President of the European section, and Editor in Chief of the International Journal of Tuberculosis and Lung Disease, and a member of NICE where he was chair of the Tuberculosis Section. He co-founded the UK Based TB charity in 1998. Dr. Davies is an expert in tuberculosis and edited the inaugural edition of the textbook, Clinical Tuberculosis in 1994 and has continued as editor for the subsequent 5 editions.
Recenzii
This sixth edition encompasses multiple aspects of Mycobacterium tuberculosis infection. Anyone actively involved in controlling tuberculosis should consider this book as a reference. It is suited to healthcare providers in both clinical and public health settings, especially if involved in tuberculosis eradication programs where complex situations arise with certain frequency. The editors and contributing authors are experts in the subject. The organization is logical for any infectious disease book, and the book strikes a good balance between depth and breadth. It is more accessible as a guideline for providers engaged in treating patients with tuberculosis or public health officers involved in eradication efforts.
Carlos E Figueroa Castro, MD(Medical College of Wisconsin)
Carlos E Figueroa Castro, MD(Medical College of Wisconsin)
Descriere
Entirely updated and revised, the 6th edition of Clinical Tuberculosis continues to provide the TB physician with a definitive and erudite account of the latest techniques in diagnosis, treatment and control of TB, including an overview of the latest guidelines from the CDC and WHO.